KIF14 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Comparison | Statistical significance |
Normal-vs-Primary | 9.047600E-01 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
9.424600E-01 |
Normal-vs-Stage2 |
1.152570E-01 |
Normal-vs-Stage3 |
9.458800E-01 |
Normal-vs-Stage4 |
5.322000E-01 |
Stage1-vs-Stage2 |
8.09730000000952E-05 |
Stage1-vs-Stage3 |
7.761200E-01 |
Stage1-vs-Stage4 |
2.566400E-01 |
Stage2-vs-Stage3 |
2.642500E-03 |
Stage2-vs-Stage4 |
2.159500E-03 |
Stage3-vs-Stage4 |
4.111000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.851400E-01 |
Normal-vs-AfricanAmerican |
4.028600E-01 |
Normal-vs-Asian |
9.903200E-01 |
Caucasian-vs-AfricanAmerican |
7.158200E-02 |
Caucasian-vs-Asian |
7.600200E-01 |
AfricanAmerican-vs-Asian |
2.185400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.961400E-01 |
Normal-vs-Female |
8.720800E-01 |
Male-vs-Female |
7.017800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.028800E-01 |
Normal-vs-Age(41-60Yrs) |
4.135600E-01 |
Normal-vs-Age(61-80Yrs) |
9.068800E-01 |
Normal-vs-Age(81-100Yrs) |
1.421610E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.958500E-03 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.881800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.154400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.826980E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.166250E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.781760E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Classical-VS-Tall |
5.595800E-01 |
Classical-VS-Follicular |
5.16929999916371E-08 |
Classical-VS-Other |
1.091190E-01 |
Classical-VS-Normal |
7.661200E-01 |
Tall-VS-Follicular |
1.710440E-02 |
Tall-VS-Other |
1.235040E-01 |
Tall-VS-Normal |
5.477800E-01 |
Follicular-VS-Other |
5.007200E-01 |
Follicular-VS-Normal |
1.178640E-01 |
Other-VS-Normal |
4.151000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.541600E-01 |
Normal-vs-N1 |
9.750600E-01 |
N0-vs-N1 |
1.030980E-01 |
|
|